Abstract
In this chapter currently available preclinical models of tumor progression and bone metastasis, including genetically engineered mice that develop primary and metastatic carcinomas and transplantable animal models, will be described. Understanding the multistep process of incurable bone metastasis is pivotal to the development of new therapeutic strategies. Novel technologies for imaging molecules or pathologic processes in cancers and their surrounding stroma have emerged rapidly and have greatly facilitated cancer research, in particular the cellular behavior of osteotropic tumors and their response to new and existing therapeutic agents. Optical imaging, in particular, has become an important tool in preclinical bone metastasis models, clinical trials and medical practice. Advances in experimental and clinical imaging will—in the long run—result in significant improvements in diagnosis, tumor localization, enhanced drug delivery and treatment.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Albini A, Sporn MB (2007) The tumour microenvironment as a target for chemoprevention. Nat Rev Cancer 7:139–147
An Z, Wang X, Geller J, Moossa AR, Hoffman RM (1998) Surgical orthotopic implantation allows high lung and lymph node metastatic expression of human prostate carcinoma cell line PC-3 in nude mice. Prostate 34:169–174
Arguello F, Baggs RB, Frantz CN (1988) A murine model of experimental metastasis to bone and bone marrow. Cancer Res 48:6876–6881
Asamoto M, Hokaiwado N, Cho YM, Takahashi S, Ikeda Y, Imaida K et al (2001) Prostate carcinomas developing in transgenic rats with SV40 T antigen expression under probasin promoter control are strictly androgen dependent. Cancer Res 61:4693–4700
Bhaumik S, Gambhir SS (2002) Optical imaging of Renilla luciferase reporter gene expression in living mice. Proc Natl Acad Sci USA 99:377–382
Bhowmick NA, Moses HL (2005) Tumor-stroma interactions. Curr Opin Genet Dev 15:97–101
Black PC, Shetty A, Brown GA, Esparza-Coss E, Metwalli AR, Agarwal PK et al (2010) Validating bladder cancer xenograft bioluminescence with magnetic resonance imaging: the significance of hypoxia and necrosis. BJU Int 106:1799–1804
Blakely CM, Sintasath L, D’Cruz CM, Hahn KT, Dugan KD, Belka GK et al (2005) Developmental stage determines the effects of MYC in the mammary epithelium. Development 132:1147–1160
Bremer C, Tung CH, Weissleder R (2001) In vivo molecular target assessment of matrix metalloproteinase inhibition. Nat Med 7:743–748
Brown RL, Reinke LM, Damerow MS, Perez D, Chodosh LA, Yang J et al (2011) CD44 splice isoform switching in human and mouse epithelium is essential for epithelial-mesenchymal transition and breast cancer progression. J Clin Invest 121:1064–1074
Buijs JT, van der Pluijm G (2009) Osteotropic cancers: from primary tumor to bone. Cancer Lett 273:177–193
Buijs JT, Rentsch CA, van der Horst G, van Overveld PG, Wetterwald A, Schwaninger R et al (2007a) BMP7, a putative regulator of epithelial homeostasis in the human prostate, is a potent inhibitor of prostate cancer bone metastasis in vivo. Am J Pathol 171:1047–1057
Buijs JT, Henriquez NV, van Overveld PG, van der Horst G, Que I, Schwaninger R et al (2007b) Bone morphogenetic protein 7 in the development and treatment of bone metastases from breast cancer. Cancer Res 67:8742–8751
Buijs JT, Cheung H, Doumont G, Derksen PW, Jonkers J, van der Pluijm G (2010) A new mouse model of invasive lobular carcinoma of the breast representative of the multi-step process of bone metastasis and minimal residual disease micrometastasis. Bone 47:S282
Cao F, Lin S, Xie X, Ray P, Patel M, Zhang X et al (2006) In vivo visualization of embryonic stem cell survival, proliferation, and migration after cardiac delivery. Circulation 113:1005–1014
Cao F, Drukker M, Lin S, Sheikh AY, Xie X, Li Z et al (2007) Molecular imaging of embryonic stem cell misbehavior and suicide gene ablation. Cloning Stem Cells 9:107–117
Caysa H, Jacob R, Muther N, Branchini B, Messerle M, Soling A (2009) A redshifted codon-optimized firefly luciferase is a sensitive reporter for bioluminescence imaging. Photochem Photobiol Sci 8:52–56
Chen Z, Trotman LC, Shaffer D, Lin HK, Dotan ZA, Niki M et al (2005) Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis. Nature 436:725–730
Coleman RE (1997) Skeletal complications of malignancy. Cancer 80:1588–1594
Contag PR, Olomu IN, Stevenson DK, Contag CH (1998) Bioluminescent indicators in living mammals. Nat Med 4:245–247
Cowey S, Szafran AA, Kappes J, Zinn KR, Siegal GP, Desmond RA et al (2007) Breast cancer metastasis to bone: evaluation of bioluminescent imaging and microSPECT/CT for detecting bone metastasis in immunodeficient mice. Clin Exp Metastasis 24(5):389–401
D’Cruz CM, Gunther EJ, Boxer RB, Hartman JL, Sintasath L, Moody SE et al (2001) c-MYC induces mammary tumorigenesis by means of a preferred pathway involving spontaneous Kras2 mutations. Nat Med 7:235–239
Derksen PW, Liu X, Saridin F, van der Gulden H, Zevenhoven J, Evers B, van Beijnum JR, Griffioen AW, Vink J, Krimpenfort P, Peterse JL, Cardiff RD, Berns A, Jonkers J (2006) Somatic inactivation of E-cadherin and p53 in mice leads to metastatic lobular mammary carcinoma through induction of anoikis resistance and angiogenesis. Cancer Cell 105:437–449
Derksen PW, Braumuller TM, van der Burg E, Hornsveld M, Mesman E, Wesseling J et al (2011) Mammary-specific inactivation of E-cadherin and p53 impairs functional gland development and leads to pleomorphic invasive lobular carcinoma in mice. Dis Model Mech 4:347–358
Drake FH, Dodds RA, James IE, Connor JR, Debouck C, Richardson S et al (1996) Cathepsin K, but not cathepsins B, L, or S, is abundantly expressed in human osteoclasts. J Biol Chem 271:12511–12516
Dubertret B, Skourides P, Norris DJ, Noireaux V, Brivanlou AH, Libchaber A (2002) In vivo imaging of quantum dots encapsulated in phospholipid micelles. Science 298:1759–1762
Franzius C, Hotfilder M, Poremba C, Hermann S, Schäfers K, Gabbert HE, Jürgens H, Schober O, Schäfers M, Vormoor J (2006) Successful high-resolution animal positron emission tomography of human Ewing tumours and their metastases in a murine xenograft model. Eur J Nucl Med Mol Imaging 33(12):1432–1441
Frese KK, Tuveson DA (2007) Maximizing mouse cancer models. Nat Rev Cancer 7:645–658
Friedl P, Gilmour D (2009) Collective cell migration in morphogenesis, regeneration and cancer. Nat Rev Mol Cell Biol 10:445–457
Futakuchi M, Nannuru KC, Varney ML, Sadanandam A, Nakao K, Asai K et al (2009) Transforming growth factor-beta signaling at the tumor-bone interface promotes mammary tumor growth and osteoclast activation. Cancer Sci 100:71–81
Gao H, Ouyang X, Banach-Petrosky W, Borowsky AD, Lin Y, Kim M et al (2004) A critical role for p27kip1 gene dosage in a mouse model of prostate carcinogenesis. Proc Natl Acad Sci USA 101:17204–17209
Gingrich JR, Greenberg NM (1996) A transgenic mouse prostate cancer model. Toxicol Pathol 24:502–504
Graves EE, Weissleder R, Ntziachristos V (2004) Fluorescence molecular imaging of small animal tumor models. Curr Mol Med 4:419–430
Gunther EJ, Belka GK, Wertheim GB, Wang J, Hartman JL, Boxer RB et al (2002) A novel doxycycline-inducible system for the transgenic analysis of mammary gland biology. FASEB J 16:283–292
Henriquez NV, van Overveld PG, Que I, Buijs JT, Bachelier R, Kaijzel EL et al (2007) Advances in optical imaging and novel model systems for cancer metastasis research. Clin Exp Metastasis 24:699–705
Hilderbrand SA, Weissleder R (2010) Near-infrared fluorescence: application to in vivo molecular imaging. Curr Opin Chem Biol 14:71–79
Hinds KA, Hill JM, Shapiro EM, Laukkanen MO, Silva AC, Combs CA et al (2003) Highly efficient endosomal labeling of progenitor and stem cells with large magnetic particles allows magnetic resonance imaging of single cells. Blood 102:867–872
Hirbe AC, Roelofs AJ, Floyd DH, Deng H, Becker SN, Lanigan LG et al (2009) The bisphosphonate zoledronic acid decreases tumor growth in bone in mice with defective osteoclasts. Bone 44(5):908–916
Hoffman RM (2009) Imaging cancer dynamics in vivo at the tumor and cellular level with fluorescent proteins. Clin Exp Metastasis 26:345–355
Hynes RO (2007) Cell-matrix adhesion in vascular development. J Thromb Haemost 5(suppl 1):32–40
Ip C (1996) Mammary tumorigenesis and chemoprevention studies in carcinogen-treated rats. J Mammary Gland Biol Neoplasia 1:37–47
Izbicka E, Dunstan CR, Horn D, Harris M, Harris S, Adams R, Mundy GR (1997) Effects of human tumor cell lines on local new bone formation in vivo. Calcif Tissue Int 602:210–215
Jaiswal JK, Mattoussi H, Mauro JM, Simon SM (2003) Long-term multiple color imaging of live cells using quantum dot bioconjugates. Nat Biotechnol 21:47–51
Jonkers J, Meuwissen R, van der Gulden H, Peterse H, van der Valk M, Berns A (2001) Synergistic tumor suppressor activity of BRCA2 and p53 in a conditional mouse model for breast cancer. Nat Genet 29:418–425
Kalluri R (2009) EMT: when epithelial cells decide to become mesenchymal-like cells. J Clin Invest 119:1417–1419
Kalluri R, Weinberg RA (2009) The basics of epithelial-mesenchymal transition. J Clin Invest 119:1420–1428
Kaijzel EL, van der Pluijm G, Lowik CW (2007) Whole-body optical imaging in animal models to assess cancer development and progression. Clin Cancer Res 13:3490–3497
Kaijzel EL, Snoeks TJ, Buijs JT, van der Pluijm G, Lowik CW (2009) Multimodal imaging and treatment of bone metastasis. Clin Exp Metastasis 26:371–379
Katz MH, Takimoto S, Spivack D, Moossa AR, Hoffman RM, Bouvet M (2003) A novel red fluorescent protein orthotopic pancreatic cancer model for the preclinical evaluation of chemotherapeutics. J Surg Res 113:151–160
Keller ET, Brown J (2004) Prostate cancer bone metastases promote both osteolytic and osteoblastic activity. J Cell Biochem 91:718–729
Khanna C, Hunter K (2005) Modeling metastasis in vivo. Carcinogenesis 26:513–523
Kim MJ, Cardiff RD, Desai N, Banach-Petrosky WA, Parsons R, Shen MM et al (2002) Cooperativity of Nkx3.1 and Pten loss of function in a mouse model of prostate carcinogenesis. Proc Natl Acad Sci USA 99:2884–2889
Kim JB, Stein R, O’Hare MJ (2005) Tumour-stromal interactions in breast cancer: the role of stroma in tumourigenesis. Tumour Biol 26:173–185
Kim JB, Urban K, Cochran E, Lee S, Ang A, Rice B, et al (2010) Non-invasive detection of a small number of bioluminescent cancer cells in vivo. PLoS One 5:e9364
Kim J, Roh M, Doubinskaia I, Algarroba GN, Eltoum IE, Abdulkadir SA (2011) A mouse model of heterogeneous, c-MYC-initiated prostate cancer with loss of Pten and p53. Oncogene 20:1–11
Korenchuk S, Lehr JE, MClean L, Lee YG, Whitney S, Vessella R et al (2001) VCaP, a cell-based model system of human prostate cancer. In Vivo 15:163–168
Kozloff KM, Weissleder R, Mahmood U (2007) Noninvasive optical detection of bone mineral. J Bone Miner Res 22:1208–1216
Kozloff KM, Quinti L, Patntirapong S, Hauschka PV, Tung CH, Weissleder R et al (2009) Non-invasive optical detection of cathepsin K-mediated fluorescence reveals osteoclast activity in vitro and in vivo. Bone 44:190–198
Kraitchman DL, Heldman AW, Atalar E, Amado LC, Martin BJ, Pittenger MF et al (2003) In vivo magnetic resonance imaging of mesenchymal stem cells in myocardial infarction. Circulation 107:2290–2293
Kuperwasser C, Dessain S, Bierbaum BE, Garnet D, Sperandio K, Gauvin GP et al (2005) A mouse model of human breast cancer metastasis to human bone. Cancer Res 65:6130–6138
Lakso M, Sauer B, Mosinger B Jr, Lee EJ, Manning RW, Yu SH et al (1992) Targeted oncogene activation by site-specific recombination in transgenic mice. Proc Natl Acad Sci USA 89:6232–6236
Lee AS, Tang C, Cao F, Xie X, van der Bogt K, Hwang A et al (2009) Effects of cell number on teratoma formation by human embryonic stem cells. Cell Cycle 8:2608–2612
Lehr HA, Leunig M, Menger MD, Nolte D, Messmer K (1993) Dorsal skinfold chamber technique for intravital microscopy in nude mice. Am J Pathol 143:1055–1062
Lewandoski M (2001) Conditional control of gene expression in the mouse. Nat Rev Genet 2:743–755
Lynch CC, Hikosaka A, Acuff HB, Martin MD, Kawai N, Singh RK et al (2005) MMP-7 promotes prostate cancer-induced osteolysis via the solubilization of RANKL. Cancer Cell 7:485–496
Massoud TF, Gambhir SS (2003) Molecular imaging in living subjects: seeing fundamental biological processes in a new light. Genes Dev 17:545–580
McCabe NP, De S, Vasanji A, Brainard J, Byzova TV (2007) Prostate cancer specific integrin alphavbeta3 modulates bone metastatic growth and tissue remodeling. Oncogene 26:6238–6243
McCarthy JR, Bhaumik J, Karver MR, Sibel ES, Weissleder R (2010) Targeted nanoagents for the detection of cancers. Mol Oncol 4:511–528
Megason SG, Fraser SE (2007) Imaging in systems biology. Cell 130:784–795
Mueller MM, Fusenig NE (2004) Friends or foes––bipolar effects of the tumour stroma in cancer. Nat Rev Cancer 4:839–849
Mundy GR (2002) Metastasis to bone: causes, consequences and therapeutic opportunities. Nat Rev Cancer 2:584–593
Naef F, Huelsken J (2005) Cell-type-specific transcriptomics in chimeric models using transcriptome-based masks. Nucl Acids Res 19:e111
Nahrendorf M, Keliher E, Marinelli B, Waterman P, Feruglio PF, Fexon L et al (2010) Hybrid PET-optical imaging using targeted probes. Proc Natl Acad Sci USA 107:7910–7915
Nakai M, Mundy GR, Williams PJ, Boyce B, Yoneda T (1992) A synthetic antagonist to laminin inhibits the formation of osteolytic metastases by human melanoma cells in nude mice. Cancer Res 52(19):5395–5399
Nakamura I, Duong lT, Rodan SB, Rodan GA (2007) Involvement of alphav)beta3 integrins in osteoclast function. J Bone Miner Metab 25:337–344
Nakatsu T, Ichiyama S, Hiratake J, Saldanha A, Kobashi N, Sakata K et al (2006) Structural basis for the spectral difference in luciferase bioluminescence. Nature 440:372–376
Nannuru KC, Futakuchi M, Sadanandam A, Wilson TJ, Varney ML, Myers KJ et al (2009) Enhanced expression and shedding of receptor activator of NF-kappaB ligand during tumor-bone interaction potentiates mammary tumor-induced osteolysis. Clin Exp Metastasis 26:797–808
Nannuru KC, Futakuchi M, Varney ML, Vincent TM, Marcusson EG, Singh RK (2010) Matrix metalloproteinase MMP-13 regulates mammary tumor-induced osteolysis by activating MMP9 and transforming growth factor-beta signaling at the tumor-bone interface. Cancer Res 70:3494–3504
Nemeth JA, Harb JF, Barroso U Jr, He Z, Grignon DJ, Cher ML (1999) Severe combined immunodeficient-hu model of human prostate cancer metastasis to human bone. Cancer Res 59:1987–1993
Nicholson B, Theodorescu D (2004) Angiogenesis and prostate cancer tumor growth. J Cell Biochem 91:125–150
O’Neill K, Lyons SK, Gallagher WM, Curran KM, Byrne AT (2010) Bioluminescent imaging: a critical tool in pre-clinical oncology research. J Pathol 220:317–327
Paget S (1889) The distribution of secondary growths in cancer of the breast. 1889. Cancer Metastasis Rev 8:98–101
Peyruchaud O, Serre CM, NicAmhlaoibh R, Fournier P, Clezardin P (2003) Angiostatin inhibits bone metastasis formation in nude mice through a direct anti-osteoclastic activity. J Biol Chem 278:45826–45832
Pollard M (1998) Lobund-Wistar rat model of prostate cancer in man. Prostate 37:1–4
Pollard M, Wolter WR, Sun L (2000) Prostate-seminal vesicle cancers induced in noble rats. Prostate 43:71–74
Power CA, Pwint H, Chan J, Cho J, Yu Y, Walsh W et al (2009) A novel model of bone-metastatic prostate cancer in immunocompetent mice. Prostate 69:1613–1623
Pulaski BA, Ostrand-Rosenberg S (2001) Mouse 4T1 breast tumor model. Curr Protoc Immunol Chap. 20:Unit 20.2
Reeves K, van der Pluijm G, Cecchini MG, Eaton CL, Hamdy FC, Brown ND (2010) A new in vivo model of prostate cancer metastasis to bone. Bone. 47:S282
Rehemtulla A, Stegman LD, Cardozo SJ, Gupta S, Hall DE, Contag CH et al (2000) Rapid and quantitative assessment of cancer treatment response using in vivo bioluminescence imaging. Neoplasia 2:491–495
Rodriguez-Porcel M, Wu, JC, Gambhir, SS (2009) Molecular imaging of stem cells (July 30, 2009). Stembook (ed) The stem cell research community, stembook. doi:10.3824/stembook.1.49.1, http://www.stembook.org
Roodman GD (2004) Mechanisms of bone metastasis. N Engl J Med 350:1655–1664
Rosol TJ, Tannehill-Gregg SH, Corn S, Schneider A, McCauley LK (2004) Animal models of bone metastasis. Cancer Treat Res 18:47–81
Rothbauer U, Zolghadr K, Tillib S, Nowak D, Schermelleh L, Gahl A et al (2006) Targeting and tracing antigens in live cells with fluorescent nanobodies. Nat Methods 3:887–889
Santos EB, Yeh R, Lee J, Nikhamin Y, Punzalan B, Punzalan B et al (2009) Sensitive in vivo imaging of T cells using a membrane-bound Gaussia princeps luciferase. Nat Med 15:338–344
Sarkisian CJ, Keister BA, Stairs DB, Boxer RB, Moody SE, Chodosh LA (2007) Dose-dependent oncogene-induced senescence in vivo and its evasion during mammary tumorigenesis. Nat Cell Biol 9:493–505
Schroeder T (2008) Imaging stem-cell-driven regeneration in mammals. Nature 453:345–351
Sckell A, Leunig M (2009) The dorsal skinfold chamber: studying angiogenesis by intravital microscopy. Methods Mol Biol 467:305–317
Schwaninger R, Rentsch CA, Wetterwald A, van der Horst G, van Bezooijen RL, van der Pluijm G et al (2007) Lack of noggin expression by cancer cells is a determinant of the osteoblast response in bone metastases. Am J Pathol 170:160–175
Serganova I, Moroz E, Vider J, Gogiberidze G, Moroz M, Pillarsetty N et al (2009) Multimodality imaging of TGFbeta signaling in breast cancer metastases. FASEB J 23:2662–2672
Shah K, Weissleder R (2005) Molecular optical imaging: applications leading to the development of present day therapeutics. NeuroRx 2:215–225
Shaner NC, Campbell RE, Steinbach PA, Giepmans BN, Palmer AE, Tsien RY (2004) Improved monomeric red, orange and yellow fluorescent proteins derived from Discosoma sp red fluorescent protein. Nat Biotechnol 22:1567–1572
Shaner NC, Steinbach PA, Tsien RY (2005) A guide to choosing fluorescent proteins. Nat Methods 2:905–909
Shcherbo D, Merzlyak EM, Chepurnykh TV, Fradkov AF, Ermakova GV, Solovieva EA et al (2007) Bright far-red fluorescent protein for whole-body imaging. Nat Methods 4:741–746
Shen Q, Brown PH (2005) Transgenic mouse models for the prevention of breast cancer. Mutat Res 576:93–110
Shtivelman E, Namikawa R (1995) Species-specific metastasis of human tumor cells in the severe combined immunodeficiency mouse engrafted with human tissue. Proc Natl Acad Sci USA 92:4661–4665
Singh M, Johnson L (2006) Using genetically engineered mouse models of cancer to aid drug development: an industry perspective. Clin Cancer Res 12:5312–5328
Snoeks TJ, Lowik CW, Kaijzel EL (2010) ‘In vivo’ optical approaches to angiogenesis imaging. Angiogenesis 13:135–147
Snoeks TJ, Khmelinskii A, Lelieveldt BP, Kaijzel EL, Lowik CW (2011) Optical advances in skeletal imaging applied to bone metastases. Bone 48:106–114
Stoica G, Koestner A, Capen CC (1983) Characterization of N-ethyl-N-nitrosourea–induced mammary tumors in the rat. Am J Pathol 110:161–169
Stoica G, Koestner A, Capen CC (1984) Neoplasms induced with high single doses of N-ethyl-N-nitrosourea in 30-day-old Sprague-Dawley rats, with special emphasis on mammary neoplasia. Anticancer Res 4:5–12
Strube A, Stepina E, Mumberg D, Scholz A, Hauff P, Käkönen SM (2010) Characterization of a new renal cell carcinoma bone metastasis mouse model. Clin Exp Metastasis 27(5):319–330
Tannous BA, Kim DE, Fernandez JL, Weissleder R, Breakefield XO (2005) Codon-optimized Gaussia luciferase cDNA for mammalian gene expression in culture and in vivo. Mol Ther 11:435–443
Tao K, Fang M, Alroy J, Sahagian GG (2008) Imagable 4T1 model for the study of late stage breast cancer. BMC Cancer 8:228
Teitelbaum SL (2000) Bone resorption by osteoclasts. Science 289:1504–1508
Thalmann GN, Sikes RA, Wu TT, Degeorges A, Chang SM, Ozen M et al (2000) LNCaP progression model of human prostate cancer: androgen-independence and osseous metastasis. Prostate 44:91–103
Thiery JP, Acloque H, Huang RY, Nieto MA (2009) Epithelial-mesenchymal transitions in development and disease. Cell 139:871–890
Tsien RY (2003) Imagining imaging’s future. Nat Rev Mol Cell Biol Suppl:SS16–SS21
Tu WH, Thomas TZ, Masumori N, Bhowmick NA, Gorska AE, Shyr Y et al (2003) The loss of TGF-beta signaling promotes prostate cancer metastasis. Neoplasia 5:267–277
van der Bogt KE, Swijnenburg RJ, Cao F, Wu JC (2006) Molecular imaging of human embryonic stem cells: keeping an eye on differentiation, tumorigenicity and immunogenicity. Cell Cycle 5:2748–2752
van Haperen R, Cheng C, Mees BM, van DE, de Waard M, van Damme LC et al (2003) Functional expression of endothelial nitric oxide synthase fused to green fluorescent protein in transgenic mice. Am J Pathol 163:1677–1686
van den Hoogen C, van der Horst G, Cheung H, Buijs JT, Lippitt JM, Guzman-Ramirez N et al (2010) High aldehyde dehydrogenase activity identifies tumor-initiating and metastasis-initiating cells in human prostate cancer. Cancer Res 70:5163–5173
van der Horst G, van Asten JJ, Figdor A, van den Hoogen C, Cheung H, Bevers RF et al (2011a) Real-time cancer cell tracking by bioluminescence in a preclinical model of human bladder cancer growth and metastasis. Eur Urol 60:337–343
van der Horst G, van den Hoogen C, Buijs JT, Cheung H, Bloys H, Pelger RC et al (2011b) Targeting of alphav)-integrins in stem/progenitor cells and supportive microenvironment impairs bone metastasis in human prostate cancer. Neoplasia 13:516–525
van der Pluijm G (2010) Epithelial plasticity, cancer stem cells and bone metastasis formation. Bone 48:37–43
van der Pluijm G, Sijmons B, Vloedgraven H, Deckers M, Papapoulos S, Lowik C (2001) Monitoring metastatic behavior of human tumor cells in mice with species-specific polymerase chain reaction: elevated expression of angiogenesis and bone resorption stimulators by breast cancer in bone metastases. J Bone Miner Res 16:1077–1091
van der Pluijm G, Que I, Sijmons B, Buijs JT, Lowik CW, Wetterwald A et al (2005) Interference with the microenvironmental support impairs the de novo formation of bone metastases in vivo. Cancer Res 65:7682–7690
Virostko J, Jansen ED (2009) Validation of bioluminescent imaging techniques. Methods Mol Biol 574:15–23
Visvader JE (2011) Cells of origin in cancer. Nature 20:314–322
Wang S, Gao J, Lei Q, Rozengurt N, Pritchard C, Jiao J et al (2003) Prostate-specific deletion of the murine Pten tumor suppressor gene leads to metastatic prostate cancer. Cancer Cell 4:209–221
Wang J, Xia TS, Liu XA, Ding Q, Du Q, Yin H et al (2010) A novel orthotopic and metastatic mouse model of breast cancer in human mammary microenvironment. Breast Cancer Res Treat 120:337–344
Weissleder R, Pittet MJ (2008) Imaging in the era of molecular oncology. Nature 452:580–589
Wetterwald A, van der Pluijm G, Que I, Sijmons B, Buijs J, Karperien M et al (2002) Optical imaging of cancer metastasis to bone marrow: a mouse model of minimal residual disease. Am J Pathol 160(3):1143–1153
Winter SF, Cooper AB, Greenberg NM (2003) Models of metastatic prostate cancer: a transgenic perspective. Prostate Cancer Prostatic Dis 6:204–211
Xia TS, Wang J, Yin H, Ding Q, Zhang YF, Yang HW et al (2010) Human tissue-specific microenvironment: an essential requirement for mouse models of breast cancer. Oncol Rep 24:203–211
Xia TS, Wang GZ, Ding Q, Liu XA, Zhou WB, Zhang YF et al (2011) Bone metastasis in a novel breast cancer mouse model containing human breast and human bone. Breast Cancer Res Treat. 3 Jan 2011 [Epub ahead of print]
Xu X, Weaver Z, Linke SP, Li C, Gotay J, Wang XW et al (1999) Centrosome amplification and a defective G2-M cell cycle checkpoint induce genetic instability in BRCA1 exon 11 isoform-deficient cells. Mol Cell 3:389–395
Yaghoubi SS, Jensen MC, Satyamurthy N, Budhiraja S, Paik D, Czernin J et al (2009) Noninvasive detection of therapeutic cytolytic T cells with 18F-FHBG PET in a patient with glioma. Nat Clin Pract Oncol 6:53–58
Yang M, Li L, Jiang P, Moossa AR, Penman S, Hoffman RM (2003) Dual-color fluorescence imaging distinguishes tumor cells from induced host angiogenic vessels and stromal cells. Proc Natl Acad Sci USA 100:14259–14262
Yonou H, Yokose T, Kamijo T, Kanomata N, Hasebe T, Nagai K et al (2001) Establishment of a novel species- and tissue-specific metastasis model of human prostate cancer in humanized non-obese diabetic/severe combined immunodeficient mice engrafted with human adult lung and bone. Cancer Res 61:2177–2182
Zaheer A, Lenkinski RE, Mahmood A, Jones AG, Cantley LC, Frangioni JV (2001) In vivo near-infrared fluorescence imaging of osteoblastic activity. Nat Biotechnol 19:1148–1154
Zhang N, Fang Z, Contag PR, Purchio AF, West DB (2004) Tracking angiogenesis induced by skin wounding and contact hypersensitivity using a Vegfr2-luciferase transgenic mouse. Blood 103:617–626
Zhang Q, Yin L, Tan Y, Yuan Z, Jiang H (2008) Quantitative bioluminescence tomography guided by diffuse optical tomography. Opt Express 16:1481–1486
Zhou Z, Flesken-Nikitin A, Corney DC, Wang W, Goodrich DW, Roy-Burman P et al (2006) Synergy of p53 and Rb deficiency in a conditional mouse model for metastatic prostate cancer. Cancer Res 66:7889–7898
Acknowledgments
The authors wish to thank Mr. Henry Cheung (Leiden Univ. Med. Ctr., dept. Urology, Leiden, the Netherlands) and Mr. Ivo Que (Leiden Univ. Med. Ctr., Dept. Endocrinology, Leiden, the Netherlands) for real-time optical imaging of osteotropic cancer cells in vivo.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
van der Horst, G., van der Pluijm, G. (2012). Preclinical Models that Illuminate the Bone Metastasis Cascade. In: Joerger, M., Gnant, M. (eds) Prevention of Bone Metastases. Recent Results in Cancer Research, vol 192. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-21892-7_1
Download citation
DOI: https://doi.org/10.1007/978-3-642-21892-7_1
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-21891-0
Online ISBN: 978-3-642-21892-7
eBook Packages: MedicineMedicine (R0)